Page last updated: 2024-08-20

dextrothyroxine and Pneumonia, Viral

dextrothyroxine has been researched along with Pneumonia, Viral in 32 studies

Research

Studies (32)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	32 (100.00)	2.80

Authors

Authors	Studies
Borges, P; Botton, MR; Freitas, M; Hentschke-Lopes, M; Mancuso, ACB; Matte, U	1
Chen, J; Cheng, Q; Fang, Z; Jia, Q; Zhao, G	1
Caly, L; Catton, MG; Druce, JD; Jans, DA; Wagstaff, KM	1
Fabbrocini, G; Patrì, A	1
Şimşek Yavuz, S; Ünal, S	1
Chaccour, C; Hammann, F; Rabinovich, NR; Ramón-García, S	1
Bray, M; Jans, D; Noël, F; Rayner, C; Wagstaff, K	1
Tapia, L	1
Anastasiou, IA; Eleftheriadou, I; Tentolouris, A; Tentolouris, N; Tsilingiris, D	1
Hajlaoui, K; Karray, M; Litaiem, N; Slouma, M; Zeglaoui, F	1
Wamae, CN	1
Rizzo, E	1
Bonilla-Aldana, DK; Dhama, K; Leblebicioglu, H; Patel, SK; Pathak, M; Rodriguez-Morales, AJ; Sah, R; Sharun, K; Singh, BR; Tiwari, R	1
Azanza, JR; Brew, J; Carmona-Torre, F; Casellas, A; Chaccour, C; Dobaño, C; Fernández, M; Giráldez, M; Hammann, F; Moncunill, G; Mota, JS; Rabinovich, R; Reina, G; Richardson, MA; Ruiz-Castillo, P; Sadaba, B; Yuste, JR	1
Freeman, PR; Horowitz, RI	1
Ahmed, SN; Banerjee, K; Dalai, CK; Nandy, M	1
Burger, JA; de Castro, CG; Gregianin, LJ	1
Allouche, M; Alwasel, S; Beyrem, H; Boufahja, F; Essid, N; Harrath, AH; Lazzem, M; Mahmoudi, E; Mansour, L	1
Alonso, DF; Farina, HG	1
Arora, VK; Behera, D; Tripathy, SK; Vora, A	1
Cao, Y; Hanafin, PO; Jermain, B; Lanusse, C; Lifschitz, A; Rao, GG	1
Barroso, J; DiNicolantonio, JJ; McCarty, M	1
Jans, DA; Wagstaff, KM	1
Hasan, M; Hasan, MN; Hosen, MJ; Jaman, J; Karim, MA; Karim, Z; Parvez, MSA; Tahsin, T	1
Gupta, SP	1
Perišić, O	1
Azañedo, D; Hernández-Vásquez, A; Vargas-Fernández, R	1
Abizanda, G; Aldaz, A; Casellas, A; Chaccour, C; Gil, AG; Hammann, F; Irigoyen-Barrio, Á; Martínez-Galán, F	1
Mega, ER	1
Almuedo-Riera, A; Camprubí, D; Grau-Pujol, B; Hurtado, JC; Krolewiecki, A; Martí-Soler, H; Muñoz, J; Soriano, A; Subirà, C	1
Accinelli, RA; Bryce-Alberti, M; Portmann-Baracco, A	1
Avcı, İY; Çetinkaya, RA; Demirtürk, N; Eser, F; Güner, R; Karalezli, A; Kayaaslan, B; Konya, P; Okumuş, N; Orhan, S; Savaşçı, Ü; Şaylan, B; Taşkın, G; Yamanel, L; Yılmaz, G	1

Reviews

4 review(s) available for dextrothyroxine and Pneumonia, Viral

Article	Year
Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials. Medicine, 2022, Oct-14, Volume: 101, Issue:41 Topics: Colchicine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Doxycycline; Humans; Imatinib Mesylate; Immunization, Passive; Immunoglobulins, Intravenous; Interferon beta-1b; Ivermectin; Lopinavir; Methylprednisolone; Network Meta-Analysis; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ritonavir	2022
Antiviral treatment of COVID-19 Turkish journal of medical sciences, 2020, 04-21, Volume: 50, Issue:SI-1 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Thiazoles	2020
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal? Cells, 2020, 09-15, Volume: 9, Issue:9 Topics: Animals; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Dengue; Dengue Virus; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Zika Virus; Zika Virus Infection	2020
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2. Current topics in medicinal chemistry, 2020, Volume: 20, Issue:26 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Gene Expression; Host-Pathogen Interactions; Humans; Hydroxychloroquine; Immunization, Passive; Ivermectin; Models, Molecular; Niclosamide; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protein Interaction Domains and Motifs; Protein Structure, Secondary; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Vaccines	2020

Trials

2 trial(s) available for dextrothyroxine and Pneumonia, Viral

Article	Year
The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol Trials, 2020, Jun-08, Volume: 21, Issue:1 Topics: Adolescent; Adult; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Ivermectin; Male; Middle Aged; Pandemics; Pilot Projects; Pneumonia, Viral; Randomized Controlled Trials as Topic; Risk Factors; SARS-CoV-2; Time Factors; Viral Load; Young Adult	2020
Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients. BMC infectious diseases, 2021, May-04, Volume: 21, Issue:1 Topics: Aged; Amides; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Ivermectin; Male; Middle Aged; Pneumonia, Viral; Prospective Studies; Pyrazines; Single-Blind Method; Treatment Outcome	2021

Article

Year

The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol

Trials, 2020, Jun-08, Volume: 21, Issue:1

Topics: Adolescent; Adult; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Ivermectin; Male; Middle Aged; Pandemics; Pilot Projects; Pneumonia, Viral; Randomized Controlled Trials as Topic; Risk Factors; SARS-CoV-2; Time Factors; Viral Load; Young Adult

2020

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.

BMC infectious diseases, 2021, May-04, Volume: 21, Issue:1

Topics: Aged; Amides; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; Azithromycin; COVID-19; COVID-19 Drug Treatment; Cytochrome P-450 CYP3A; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Ivermectin; Male; Middle Aged; Pneumonia, Viral; Prospective Studies; Pyrazines; Single-Blind Method; Treatment Outcome

2021

Other Studies

26 other study(ies) available for dextrothyroxine and Pneumonia, Viral

Article	Year
Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency. Cadernos de saude publica, 2022, Volume: 38, Issue:7 Topics: Azithromycin; Brazil; Coronavirus Infections; COVID-19 Drug Treatment; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral	2022
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral research, 2020, Volume: 178 Topics: Animals; Antiviral Agents; Australia; Betacoronavirus; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Drug Approval; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Virus Replication	2020
Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment? Journal of the American Academy of Dermatology, 2020, Volume: 82, Issue:6 Topics: Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Ivermectin and COVID-19: Keeping Rigor in Times of Urgency. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses. Antiviral research, 2020, Volume: 178 Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
COVID-19 and Fake News in the Dominican Republic. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Betacoronavirus; Civil Disorders; Coronavirus Infections; COVID-19; Dissent and Disputes; Dominican Republic; Drug Repositioning; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; Politics; Public Health; SARS-CoV-2; Social Media; Trust	2020
In Vitro Data of Current Therapies for SARS-CoV-2. Current medicinal chemistry, 2020, Volume: 27, Issue:27 Topics: Adenosine Monophosphate; Alanine; Betacoronavirus; China; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Emetine; Homoharringtonine; Humans; Hydroxychloroquine; Ivermectin; Lopinavir; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Teicoplanin; Thiazoles	2020
Acute generalized exanthematous pustulosis after COVID-19 treatment with hydroxychloroquine. Dermatologic therapy, 2020, Volume: 33, Issue:4 Topics: Acute Generalized Exanthematous Pustulosis; Betacoronavirus; Chemoprevention; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Mass Drug Administration and Worms Experience in Africa: Envisage Repurposing Ivermectin for SARS-COV-2. The American journal of tropical medicine and hygiene, 2020, Volume: 103, Issue:1 Topics: Africa; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Humans; Ivermectin; Onchocerciasis, Ocular; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Ivermectin, antiviral properties and COVID-19: a possible new mechanism of action. Naunyn-Schmiedeberg's archives of pharmacology, 2020, Volume: 393, Issue:7 Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19. Annals of clinical microbiology and antimicrobials, 2020, 05-30, Volume: 19, Issue:1 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus	2020
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials. Medical hypotheses, 2020, Volume: 143 Topics: Acetazolamide; Anti-Inflammatory Agents; Anticoagulants; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Testing; Diet Therapy; Humans; Immune System; Inflammation; Ivermectin; Mass Screening; NF-E2-Related Factor 2; NF-kappa B; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Resource Allocation; Risk; Sildenafil Citrate; Treatment Outcome	2020
The Battle against COVID 19 Pandemic: What we Need to Know Before we "Test Fire" Ivermectin. Drug research, 2020, Volume: 70, Issue:8 Topics: Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia and could inform clinical repurposing for COVID-19 infection. Leukemia & lymphoma, 2020, Volume: 61, Issue:10 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Ivermectin; Leukemia, Myeloid, Acute; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Ecotoxic response of nematodes to ivermectin, a potential anti-COVID-19 drug treatment. Marine pollution bulletin, 2020, Volume: 157 Topics: Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; France; Humans; Italy; Ivermectin; Mediterranean Sea; Nematoda; Pandemics; Pneumonia, Viral; SARS-CoV-2; Spain	2020
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms? International journal of antimicrobial agents, 2020, Volume: 56, Issue:3 Topics: Anticholesteremic Agents; Antineoplastic Agents; Antiparasitic Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Host-Pathogen Interactions; Humans; Hypoglycemic Agents; Ivermectin; Lovastatin; Metformin; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thiazoles	2020
White paper on Ivermectin as a potential therapy for COVID-19. The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3 Topics: Antiparasitic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Ivermectin; Pandemics; Pneumonia, Viral; Risk Factors; SARS-CoV-2; Treatment Outcome	2020
Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing. Journal of pharmaceutical sciences, 2020, Volume: 109, Issue:12 Topics: Administration, Oral; Animals; Antiviral Agents; Betacoronavirus; Cattle; Computer Simulation; Coronavirus Infections; COVID-19; Drug Repositioning; Humans; Ivermectin; Lung; Models, Biological; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19. Open heart, 2020, Volume: 7, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drugs, Essential; Host-Pathogen Interactions; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome	2020
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach. International journal of biological macromolecules, 2020, Nov-15, Volume: 163 Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Fidaxomicin; Humans; Ivermectin; Molecular Docking Simulation; Pandemics; Pneumonia, Viral; Rifabutin; Rifampin; RNA-Dependent RNA Polymerase; SARS-CoV-2; Virus Replication	2020
Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein-Drug and Protein-Protein Structures: An Analysis of Kinetically Active Residues. Biomolecules, 2020, 09-21, Volume: 10, Issue:9 Topics: Adenosine Monophosphate; Alanine; Angiotensin-Converting Enzyme 2; Antibodies, Viral; Antigen-Antibody Reactions; Antiviral Agents; Betacoronavirus; Binding Sites; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Eflornithine; Humans; Hydrophobic and Hydrophilic Interactions; Ivermectin; L-Lactate Dehydrogenase; Models, Molecular; Molecular Docking Simulation; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Proline; Protein Binding; Protein Conformation; Protein Interaction Mapping; Receptors, Glycine; Saposins; SARS-CoV-2; Sofosbuvir; Spike Glycoprotein, Coronavirus; Structure-Activity Relationship	2020
Considerations on the Article "Antiviral and Anti-Inflammatory Properties of Ivermectin and its Potential Use in COVID-19". Archivos de bronconeumologia, 2020, Volume: 56, Issue:12 Topics: Anti-Inflammatory Agents; Antiviral Agents; COVID-19; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats. Scientific reports, 2020, 10-13, Volume: 10, Issue:1 Topics: Administration, Inhalation; Animals; Antiparasitic Agents; Behavior, Animal; Coronavirus Infections; COVID-19; Dose-Response Relationship, Drug; Female; Half-Life; Ivermectin; Lung; Male; Necrosis; Pandemics; Pneumonia, Viral; Proof of Concept Study; Rats; Rats, Sprague-Dawley; Respiration Disorders	2020
Latin America's embrace of an unproven COVID treatment is hindering drug trials. Nature, 2020, Volume: 586, Issue:7830 Topics: Animals; Clinical Trials as Topic; Coronavirus Infections; COVID-19; Evidence-Based Medicine; Humans; Ivermectin; Latin America; Pandemics; Pneumonia, Viral; Reproducibility of Results; Retraction of Publication as Topic	2020
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients. PloS one, 2020, Volume: 15, Issue:11 Topics: Adult; Antibodies, Monoclonal, Humanized; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; Humans; Immunosuppressive Agents; Ivermectin; Male; Middle Aged; Nasopharynx; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Treatment Outcome	2020
Reply to "Antiviral and anti-inflammatory properties of ivermectinand its potential use in COVID-19". Archivos de bronconeumologia, 2020, Volume: 56, Issue:12 Topics: Anti-Inflammatory Agents; Antiviral Agents; COVID-19 Drug Treatment; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020